Therapeutic targeting of the LncRNA IMSET suppresses inflammation and atherosclerotic plaque progression
The bispecific anti-FGFR1/KLB agonist antibody bFKB1 attenuates non-alcoholic steatohepatitis and atherosclerosis in Ldlr-/-.Leiden mice
Temporal changes in coronary plaque as assessed by an artificial intelligence based optical coherence tomography (OCT): from the first-in-human trial on dreams 3G scaffold